Results 51 to 60 of about 31,665,392 (202)

Flow chart of Virtual screening, pharmacophore-based filtering and experimental screening strategy for identifying efflux inhibitors.

open access: yes, 2014
Flow chart of Virtual screening, pharmacophore-based filtering and experimental screening strategy for identifying efflux inhibitors.
Kesavan Dineshkumar (598243)   +4 more
core   +1 more source

Discovery of novel 4-hydroxyquinolines as indoleamine 2, 3-dioxygenase 1 inhibitors by virtual screening

open access: yesDi-san junyi daxue xuebao, 2019
Objective To discover novel indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors with new scaffold structures by screening ZINC and Chembridge databases using pharmacophore modeling and molecular docking.
ZHANG Yuping, SHAN Changyu, GUO Haiqiong
doaj   +1 more source

PharmacoNet: Accelerating Large-Scale Virtual Screening by Deep Pharmacophore Modeling [PDF]

open access: yes, 2023
As the size of accessible compound libraries expands to over 10 billion, the need for more efficient structure-based virtual screening methods is emerging. Different pre-screening methods have been developed for rapid screening, but there is still a lack
Kim, Woo Youn, Seo, Seonghwan
core   +2 more sources

Development and application of fast fuzzy pharmacophore-based virtual screening methods for scaffold hopping [PDF]

open access: yes, 2006
The goal of this thesis was the development, evaluation and application of novel virtual screening approaches for the rational compilation of high quality pharmacological screening libraries. The criteria for a high quality were a high probability of the
Renner, Steffen
core  

Pharmacophore-based virtual screening, molecular docking, and molecular dynamics studies for the discovery of novel FLT3 inhibitors

open access: yes, 2022
FLT3 is considered a potential target of acute myeloid leukemia therapy. In this study, we applied a computer-aided methodology unifying molecular docking and pharmacophore screening to identify potent inhibitors against FLT3.
Souad Elkhattabi (13802147)   +5 more
core   +1 more source

Discovery of Potential M2 Channel Inhibitors Based on the Amantadine Scaffold via Virtual Screening and Pharmacophore Modeling

open access: yesMolecules, 2011
The M2 channel protein on the influenza A virus membrane has become the main target of the anti-flu drugs amantadine and rimantadine. The structure of the M2 channel proteins of the H3N2 (PDB code 2RLF) and 2009-H1N1 (Genbank accession number GQ385383 ...
Ly Le   +5 more
doaj   +1 more source

Novel Approach for Efficient Pharmacophore-Based Virtual Screening: Method and Applications

open access: yesJournal of Chemical Information and Modeling, 2009
Virtual screening is emerging as a productive and cost-effective technology in rational drug design for the identification of novel lead compounds. An important model for virtual screening is the pharmacophore. Pharmacophore is the spatial configuration of essential features that enable a ligand molecule to interact with a specific target receptor.
Oranit Dror   +4 more
openaire   +4 more sources

Ligand-based Pharmacophore Modeling, Virtual Screening and Molecular Docking Studies for Discovery of Potential Topoisomerase I Inhibitors

open access: yesComputational and Structural Biotechnology Journal, 2019
Camptothecin (CPT), a natural product and its synthetic derivatives exert potent anticancer activity by selectively targeting DNA Topoisomerase I (Top1) enzyme.
Sourav Pal   +6 more
doaj   +1 more source

Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma

open access: yes, 2022
The mortality of cancer patients with neuroblastoma is increasing due to the limited availability of specific treatment options. Few drug candidates for combating neuroblastoma have been developed, and identifying novel therapeutic candidates against the
Nouf H. Alsubhi   +20 more
core   +1 more source

PharmacoForge: pharmacophore generation with diffusion models

open access: yesFrontiers in Bioinformatics
Structure-based drug design (SBDD) is enhanced by machine learning (ML) to improve both virtual screening and de novo design. Despite advances in ML tools for both strategies, screening remains bounded by time and computational cost, while generative ...
Emma L. Flynn   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy